Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.3K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.3K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.4K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.8K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.5K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.5K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network report.

Open respiratory archives·2026
Same author

Pirfenidone and nintedanib in fibrosing interstitial lung disease: A retrospective study based on a regional university hospital data registry and literature review.

International journal of clinical pharmacology and therapeutics·2026
Same author

Sucrose-derived & silver-enriched carbon foams as prospective biocompatible and antimicrobial 3D scaffolds for biomedical applications.

Biomaterials advances·2026
Same author

Impact of Dexamethasone on Respiratory Sequelae in the Follow-Up of Hospitalized Patients with Sars-Cov-2 Pneumonia.

Infection and drug resistance·2026
Same author

Long-Term Prognosis and Transition Period until Progression in Fibrotic Hypersensitivity Pneumonitis.

Respiration; international review of thoracic diseases·2026
Same author

Role of HER2 in Response to Neoadjuvant Endocrine Therapy in Luminal Breast Cancer.

Current oncology (Toronto, Ont.)·2026

相关实验视频

Updated: Jan 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K

严重喘恶化:从风险因素到精确管理策略

Marina Paredes1, Jeisson Osorio1, Alberto García de la Fuente2

  • 1Pulmonology Department, Hospital Clínic de Barcelona and Universitat de Barcelona, 08036 Barcelona, Spain.

Journal of clinical medicine
|January 28, 2026
PubMed
概括

严重喘恶化 (SAE) 是复杂的. 生物标志物,如血中乙氨基基细胞计数 (BEC) 和分数呼出的氧化 (FeNO),有助于个性化治疗,以获得更好的结果.

关键词:
生物标志物 生物标志物埃索诺菲尔性喘是什么意思倾向于恶化的恶化.重症监护室的重症监护室是重症监护室的重症监护室.治疗治疗治疗治疗治疗治疗

更多相关视频

Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.3K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.5K

相关实验视频

Last Updated: Jan 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
Murine Model of Allergen Induced Asthma
08:05

Murine Model of Allergen Induced Asthma

Published on: May 14, 2012

41.3K
Acupuncture in a Rat Model of Asthma
07:14

Acupuncture in a Rat Model of Asthma

Published on: August 25, 2020

6.5K

科学领域:

  • 肺部病理学 肺部病理学
  • 免疫学 免疫学 免疫学
  • 临床医学 临床医学

背景情况:

  • 严重喘恶化 (SAE) 造成严重的发病率,死亡率和医疗保健挑战.
  • 一部分患者经历了反复发生的SAE,尽管目前的治疗方法.
  • 了解风险因素和现象型对于管理这些事件至关重要.

研究的目的:

  • 审查SAE的风险因素,表型和生物标志物.
  • 探索针对高调企业的个性化急性管理策略.
  • 分析2型 (T2) 生物标志物在指导治疗中的作用.

主要方法:

  • 关于SAE的临床,炎症和环境驱动因素的综合文献综述.
  • 对2型 (T2) 生物标志物的集中分析:血液中乙酸细胞计数 (BEC) 和部分呼出的氧化 (FeNO).
  • 对生物疗法对恶化的新兴证据的评估.

主要成果:

  • SAE表现出异质的原因和炎症概况;感染,过敏原,肥胖和并发症是关键的危险因素.
  • 2型 (T2) 高水平的SAE对皮质类固醇和生物药物反应更好,而不是T2低水平的SAE.
  • BEC和FeNO预测了恶化的风险和皮质类固醇反应;抗IL-5和抗TSLP等生物药物在急性护理中显示出潜力.

结论:

  • 以生物标志物为指导的管理可以提高治疗精度,减少SAE的过度治疗.
  • 在急性护理中整合表型和内型评估可能会提高患者的治疗结果和资源利用率.
  • 需要进一步的前性试验来验证这些个性化方法.